Cognex Co. (NASDAQ:CGNX) Stake Raised by Cambridge Investment Research Advisors Inc.

Cambridge Investment Research Advisors Inc. lifted its stake in shares of Cognex Co. (NASDAQ:CGNX) by 41.3% during the first quarter, HoldingsChannel.com reports. The firm owned 12,170 shares of the scientific and technical instruments company’s stock after purchasing an additional 3,558 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Cognex were worth $619,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in the company. Iberiabank Corp raised its position in shares of Cognex by 3.8% during the first quarter. Iberiabank Corp now owns 6,224 shares of the scientific and technical instruments company’s stock worth $317,000 after purchasing an additional 229 shares during the period. Candriam Luxembourg S.C.A. raised its position in shares of Cognex by 2.9% during the first quarter. Candriam Luxembourg S.C.A. now owns 8,859 shares of the scientific and technical instruments company’s stock worth $451,000 after purchasing an additional 248 shares during the period. Private Capital Group LLC raised its position in shares of Cognex by 50.7% during the first quarter. Private Capital Group LLC now owns 847 shares of the scientific and technical instruments company’s stock worth $43,000 after purchasing an additional 285 shares during the period. Bronfman E.L. Rothschild L.P. raised its position in Cognex by 9.6% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 3,822 shares of the scientific and technical instruments company’s stock valued at $148,000 after buying an additional 335 shares during the period. Finally, Bbva Compass Bancshares Inc. raised its position in Cognex by 2.0% during the first quarter. Bbva Compass Bancshares Inc. now owns 18,569 shares of the scientific and technical instruments company’s stock valued at $944,000 after buying an additional 366 shares during the period. 94.53% of the stock is currently owned by institutional investors.

In other news, insider John J. Curran sold 50,000 shares of the company’s stock in a transaction dated Friday, May 3rd. The stock was sold at an average price of $49.01, for a total transaction of $2,450,500.00. Following the completion of the sale, the insider now owns 12,500 shares in the company, valued at approximately $612,625. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 5.60% of the company’s stock.

CGNX has been the topic of several recent analyst reports. Zacks Investment Research lowered Cognex from a “buy” rating to a “hold” rating in a research report on Wednesday, February 13th. BidaskClub lowered Cognex from a “strong-buy” rating to a “buy” rating in a research report on Thursday, March 7th. Needham & Company LLC lowered Cognex from a “buy” rating to a “hold” rating in a research report on Tuesday, April 30th. Gordon Haskett initiated coverage on Cognex in a research report on Wednesday, April 17th. They set a “hold” rating and a $54.00 price target on the stock. Finally, ValuEngine raised Cognex from a “sell” rating to a “hold” rating in a research report on Monday, February 25th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the stock. Cognex has an average rating of “Hold” and a consensus target price of $52.20.

CGNX opened at $45.47 on Wednesday. The stock has a market cap of $7.60 billion, a PE ratio of 36.67, a P/E/G ratio of 2.91 and a beta of 2.02. Cognex Co. has a 52-week low of $34.88 and a 52-week high of $59.18. The company has a quick ratio of 7.46, a current ratio of 8.31 and a debt-to-equity ratio of 0.01.

Cognex (NASDAQ:CGNX) last released its quarterly earnings results on Monday, April 29th. The scientific and technical instruments company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.03. The company had revenue of $173.50 million during the quarter, compared to the consensus estimate of $172.16 million. Cognex had a return on equity of 18.90% and a net margin of 26.55%. The firm’s revenue was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.21 EPS. On average, equities research analysts forecast that Cognex Co. will post 1.02 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, May 31st. Stockholders of record on Friday, May 17th were paid a dividend of $0.05 per share. The ex-dividend date was Thursday, May 16th. This represents a $0.20 annualized dividend and a dividend yield of 0.44%. Cognex’s dividend payout ratio (DPR) is presently 16.13%.

TRADEMARK VIOLATION NOTICE: This article was first reported by Markets Daily and is the property of of Markets Daily. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.themarketsdaily.com/2019/06/12/cognex-co-nasdaqcgnx-stake-raised-by-cambridge-investment-research-advisors-inc.html.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Recommended Story: How to Invest in the Dividend Aristocrat Index

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.